NASID Framework

The NASID Conference was a resounding success thanks to so many of you! The panel discussions elicited a number of priorities and recommendations for the NASID national strategic framework. The following key themes emerged:

  • Prioritization of multiple substance impaired driving
  • Data challenges and gaps
  • Roadside testing with field sobriety tests and other emerging technologies
  • Expanding toxicology testing and lab capacity
  • Educating policy makers and other key stakeholders on the issues of multiple substance impaired driving
  • Focus and support for impaired driving enforcement

The input from the attendees helped us achieve a key objective of this conference by providing the board with recommendations that can be molded in a national strategic framework and providing recommendations to the membership on key priorities for 2022. NASID will hold a meeting in October for members to work through the various ideas presented in this impressive list. If you would like to add a priority to the NASID framework that is not listed here, please contact NASID Director Darrin Grondel at [email protected]

Priority Areas

Goal:  Conduct a data assessment survey to identify the gaps in drugged driving data  

Goal: NASID to work with the Association of Transportation Safety Information Professionals (ATSIP) to support changes to the FBI reporting requirements for DUI data collection

  • ATSIP has completed the survey that will be disseminated to law enforcement agencies, courts, state highway safety offices and traffic records coordinating committees to glean data addressing gaps in reporting to the National Incident-Based Reporting System (NIBRS), formally known as the Uniform Crime Report (UCR). Ron Replogle and Darrin Grondel are members of this ATSIP working group and will present on a panel at the ATSIP Annual Meeting.

Goal: NASID to support and promote the Drug Recognition Evaluation (DRE) data – tablet 

  • The Institute of Traffic Safety Management and Research is now represented with NASID.

Goal: Conduct 4 green lab trainings for all traffic safety stakeholders, to include a research component

  • January 22 – Maryland Green Lab with go-karts
  • March 31 – Maryland Green Lab
  • June 23 – Ohio State Green Lab
  • June 24 – Washington State Green Lab
  • December 7 – Las Vegas, Nevada

Goal: NASID to Present at key conferences and other meetings

  • February 5 – National Sheriff’s Association Traffic Safety Committee – Washington, D.C.
  • February 24-25 – DTG Recycling – Seattle, WA
  • March 2 – Ohio Narcotics Intelligence and Law Enforcement Conference – Virtual
  • March 9 – Ohio Public Safety Response Team – Virtual
  • March 15 – American Traffic Safety Services Association – Fargo, ND
  • March 22 – Cannabis Laws Webinar – Virtual
  • March 29 – Minnesota Legislature Oral Fluid Roadside Screening Summit
  • April 18 – Maryland Traffic Safety Conference – Baltimore, MD
  • April 22 – Oregon Traffic Safety Conference – Bend, OR
  • April 24 – Indiana Traffic Safety Conference – Indianapolis, IN
  • April 27 – South Dakota Rural Electrical Association, Watertown, SD
  • May 18 – Louisiana DUI Task Force – Oral Fluid Discussion - Virtual
  • June 6 – Cannabis Regulators Association CANNRA - Underage consumption and impaired driving panel – Seattle, WA
  • June 26 – National Sheriffs Association Conference – Traffic Safety Committee – Kansas City, MO
  • June 28 – Cannabis in the workplace – Foley LLP Webinar
  • July 6 – Washington D.C. DUI Task Force – NASID Introduction and Oral Fluid - Virtual
  • July 12 – Connecticut National Association of State Transportation Officials – Hartford, CT
  • July 18 – Colorado Traffic Safety Conference – Loveland, CO
  • July 27-29 – NASID Conference – Washington, D.C.
  • August 1-3 – NCSL Annual Conference – Denver, CO
  • August 7-10 – ATSIP Annual Conference – Denver, CO
  • August 17 – NHTSA Labor Day High Visibility Campaign Kick-off Call (Darrin Presenting)
  • August 20-24 – IACP IDTS Conference – San Antonio, TX
  • August 28-31 – International Council on Alcohol, Drugs, and Traffic Safety Conference (ICADTS) – Rotterdam, Netherlands

Goal: Support other partners training programs and efforts

Goal: Create training programs or materials addressing multiple substance Impaired Driving

  • National District Attorneys Association – Prosecuting the Drugged Driver with CLE credits
    • This course is designed to assist prosecutors in honing the skills required to properly prosecute a drug-impaired driving case. A prosecutor participating in this Drug-Impaired Driving online training will learn the following:
      1. What a drug is and what kinds of drugs can cause impairment. Although the definition of "drug" may vary by State statute, participants will learn about over-the-counter drugs, prescription drugs, illicit drugs, and what polydrug-use is.
      2. How to decipher a toxicology report and the kind of information about which a toxicologist may testify and about which he/she cannot.
      3. How a law enforcement officer fully and properly investigates a drug-impaired driving case, what the Drug Evaluation and Classification (DEC) Program is, and how a Drug Recognition Expert (DRE) may be utilized during a drug-impaired driving investigation.
      4. Some of the unique challenges and defenses posed to a drug-impaired driving prosecutor and how to best handle those challenges and defenses.
      5. Suggestions on how to select jurors for a drug-impaired driving case
  • Promotion of Law Enforcement Silver Tips for providing DUI testimony

Goal: Coordinate training for SFST, ARIDE, DRE

Goal: Support funding efforts for law enforcement and DUI from tax revenues for DUI efforts

Goal: Employ the survey recommendations from SOFT to identify key priorities with state labs

Goal: Promote the NSC recommendations for standardization for toxicology for DUI cases

  • Funding is a major barrier for labs reaching full compliance with the NSC recommendations, NASID supports and works to lobby legislative initiatives securing/earmarking some portion of tax revenue from the commercial sale of cannabis in states for use to support tox labs within states

Goal: Incorporate toxicology for public health

Goal: Develop a judicial and toxicology training program

  • Updated Monograph for Drug Toxicology for Prosecutors – NDAA NTLC Winter of 2022

Goal: Develop toxicology validation library of research

Goal: Prioritize 5 states for oral fluid policy

  • March 29 – Minnesota Legislature Oral Fluid Roadside Screening Summit
  • May 18 - Louisiana
  • Michigan, Ohio
  • AAA oral fluid drug testing and/or roadside screening programs toolkit for advocacy
  • Montana, Louisiana

Goal: Advocate for electronic search warrants in 3 states

  • Maryland, Oregon

Goal: Coordinate with National Conference of State Legislatures (NCSL) in conducting training on multiple substance impairment

  • NCSL pre-Conference Session for legislators on multiple substance impaired driving July 31 – Denver, CO
  • August 1-2 – NCSL will be hosting a pre-conference meeting and NASID will be presenting

Goal: Support of ignition interlock legislation and reciprocity

  • Hawaii, Colorado, New Hampshire, Tennessee, Minnesota, Arizona, Kansas, Louisiana, Utah, Florida, Wisconsin, Maryland, Georgia, Alabama, West Virginia, Michigan, Iowa, South Carolina

Goal: Screening and assessment and treatment legislation for Substance Abuse Disorder

  • Louisiana applies the Computerized Assessment and Referral Screening (CARS) tool as mandated by their Supreme Court
  • Nevada poised to take this on for their specialty courts and provisions are being established to get CARS

Goal: Prioritize key DUI countermeasures in preparations for state and federal Cannabis legalization efforts

Goal: Create a policy/education program with a priority list for policy makers considering legalization of cannabis

  • Cannabis State Laws Map State Laws - National Alliance to Stop Impaired Driving (nasid.org)
    • Outreach to the following state’s legislatures offering our services related to cannabis legislation – Delaware, Hawaii, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Missouri, Nebraska, New Hampshire, Ohio, Pennsylvania, Rhode Island, Tennessee, West Virginia

Goal: Design an educational component of NASID for legislators, city managers, schools, community, other policy makers

Goal: Work with NIH and other professional medical/health professionals to prioritize impairing medications with patients

Goal: Public awareness campaigns -teens (SADD)

Goal: Provide grants to states for DUID countermeasures (phlebotomy, toxicology, data enhancements, etc)

  • GHSA and Responsibility.org/NASID Awarded 6 State Grants for 2022
  • Connecticut - Green Lab/Alcohol Wet Lab combination
  • Illinois - adding validations for expanding drug testing
  • Louisiana - two grants awarded (1) purchase of toxicology equipment to conduct expanded drug testing, especially multiple substances, (2) creation of a toxicology subject matter expert program to provide testimony and consultation for prosecutors
  • Maryland - conduct 8 green labs across the state for training for criminal justice professionals, safety managers, and others for impairment detection
  • Nevada - computerized Assessment and Referral System (CARS) statewide training for judges to use for screening and assessment of DUI defendants

Goal: Fundraising – NASID activities and NASID Conference

  • Conference registration early bird fee is $250
  • Fund raising and membership is available through Joey Ford

Goal: Create a best practice guide for oral fluid state policy

Goal: Establish an oral fluid legislative guide or white paper and presentation one-pager

Goal: Conduct 4 oral fluid workshops in different states

  • March 29 – Minnesota Legislature Oral Fluid Roadside Screening Summit

Goal: Identify states to prioritize for oral fluid

  • LA, MI, MN, OH, WA, WI

Goal: Research messaging that communicates the dangers of drugs to users/consumers and how they can engage in safety (4)

Campaign messaging will need to be tailored to different classes of drugs. This is noted necessarily referring to the DECP categories, but more so to Rx/OTC, cannabis, and illicit drugs of abuse.